Clinical Nutrition Market by Route of Administration (Oral, Enteral, and Parenteral), Application (Cancer, Neurological Diseases, Gastrointestinal Disorders, Metabolic Disorders, and Others), and End User (Pediatric, Adults, and Geriatric): Global Opportunity Analysis and Industry Forecast, 2019-2026
- Published Date: 2020-11-18
- Report ID: 18192
- Pages: 200
-
Format:
The global clinical nutrition market size was valued at $313.578 billion in 2018, and is projected to reach $552.503 billion by 2026, growing at a CAGR of 5.3% from 2019-2026. Clinical nutrition product is a type of pharmaceutical product that helps to keep a patient healthy. It helps to improve the metabolic system by providing adequate supplements such as minerals, vitamins, and others. Clinical nutrition diagnose and treat diseases that affect the intake, intestinal absorption, and metabolism of constituents of the diet, and help promote health through prevention of diet-related diseases. It works in both acute and ambulatory care settings, which includes cardiac rehabilitation, renal dialysis, diabetes, pediatrics, nutrition support, cancer, trauma, wellness centers, and community-based intervention programs.
There is an increase in the demand for clinical nutrition owing to increase in chronic and lifestyle related disease such as inflammatory bowel disease and diabetes mellitus. Furthermore, rise in geriatric population and rise in population of a baby boomers further contributes to the market growth. Moreover, rise in R&D investments made by government in the healthcare sector drives the growth of the clinical nutrition market. However, lack of awareness and stringent regulations restrain the market growth. On the contrary, rise in advancements in clinical nutrition. Further, rise in demand of the clinical nutrition in the emerging countries such as Asia-Pacific and LAMEA and increase in home care usage of the nutritional products are expected to offer lucrative opportunities for the global clinical nutrition market players.
The global clinical nutrition market is segmented on the basis of route of administration, application, end user, and region. By route of administration, the market is classified into oral, enteral, and parenteral. On the basis of application, the market is categorized into cancer, neurological diseases, gastrointestinal disorders, metabolic disorders, and others. By end user, the market is segmented into pediatric, adults, and geriatric. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
KEY BENEFITS FOR STAKEHOLDERS
This report provides a detailed quantitative analysis of the current market trends and future estimations from 2019-2026, which assists to identify the prevailing market opportunities.
An in-depth analysis of various regions is anticipated to provide a detailed understanding of the current trends to enable stakeholders to formulate region-specific plans.
A comprehensive analysis of the factors that drive and restrain the growth of the global clinical nutrition market is provided.
An extensive analysis of various regions provides insights that allow companies to strategically plan their business moves.
KEY MARKET SEGMENTS
By Route Of Administration
Oral
Enteral
Parenteral
By Application
Cancer
Neurological Diseases
Gastrointestinal Disorders
Metabolic Disorders
Others
By End User
Pediatric
Adults
Geriatric
By Region
North America
o U.S.
o Canada
o Mexico
Europe
o Germany
o France
o Spain
o Italy
o UK
o Rest of Europe
Asia-Pacific
o Japan
o India
o China
o Australia
o Rest of Asia-Pacific
LAMEA
o Brazil
o Saudi Arabia
o South Africa
o Rest of LAMEA
KEY MARKET PLAYERS
Abbott Laboratories
B. Braun Melsungen AG
Danone Nutricia
Baxter International Inc.
Fresenius SE & Co. KGaA
Perrigo Company Plc
Pfizer Inc
Nestl S.A
Lonza Ltd
Hero Nutritionals Inc
The other players in the value chain (profiles not included in the report)
Quantel laser
Nidek CO., LTD.
Topcon Corporation
DEKA M.E.L.A. S.r.l.
SharpLight Technologies
Sciton, Inc.
Alma Lasers
CHAPTER 1:INTRODUCTION
1.1.Report description
1.2.Key benefits for stakeholders
1.3.Key market segments
1.4.Research methodology
1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools & models
CHAPTER 2:EXECUTIVE SUMMARY
2.1.Key findings of the study
2.2.CXO perspective
CHAPTER 3:MARKET OVERVIEW
3.1.Market definition and scope
3.2.Key Findings
3.2.1.Top Investment Pockets
3.3.Market dynamics
3.3.1.Drivers
3.3.1.1.Rise in incidence of chronic diseases and lifestyle associated disease
3.3.1.2.Surge in geriatric population across the globe
3.3.2.Restraint
3.3.2.1.Lack of awareness for clinical nutrition
3.3.3.Opportunity
3.3.3.1.Various growth opportunities in emerging economies
CHAPTER 4:CLINICAL NUTRITION MARKET, BY ROUTE OF ADMINISTRATION
4.1.Overview
4.1.1.Market size and forecast
4.2.Oral
4.2.1.Key market trends and opportunities
4.2.2.Market size and forecast
4.2.3.Market analysis, by country
4.3.Enteral
4.3.1.Key trends and opportunities
4.3.2.Market size and forecast
4.3.3.Market analysis, by country
4.4.Parenteral
4.4.1.Key market trends and opportunities
4.4.2.Market size and forecast
4.4.3.Market analysis, by country
CHAPTER 5:CLINICAL NUTRITION MARKET, BY APPLICATION
5.1.Overview
5.1.1.Market size and forecast
5.2.Cancer
5.2.1.Market size and forecast
5.2.2.Market analysis, by country
5.3.Neurological Diseases
5.3.1.Market size and forecast
5.3.2.Market analysis, by country
5.4.Gastrointestinal Disorders
5.4.1.Market size and forecast
5.4.2.Market analysis, by country
5.5.Metabolic Disorders
5.5.1.Market size and forecast
5.5.2.Market analysis, by country
5.6.Others
5.6.1.Market size and forecast
5.6.2.Market analysis, by country
CHAPTER 6:CLINICAL NUTRITION MARKET, BY END USER
6.1.Overview
6.1.1.Market size and forecast
6.2.Pediatric
6.2.1.Market size and forecast
6.2.2.Market analysis, by country
6.3.Adults
6.3.1.Market size and forecast
6.3.2.Market analysis, by country
6.4.Geriatric
6.4.1.Market size and forecast
6.4.2.Market analysis, by country
CHAPTER 7:CLINICAL NUTRITION MARKET, BY REGION
7.1.Overview
7.1.1.Market size and forecast
7.2.North America
7.2.1.Key trends and opportunities
7.2.2.market size and forecast, by country
7.2.3.market size and forecast, by route of administration
7.2.4.Market size and forecast, by application
7.2.5.market size and forecast, by end user
7.2.6.U.S.
7.2.6.1.U.S. market size and forecast, by route of administration
7.2.6.2.U.S. market size and forecast, by application
7.2.6.3.U.S. market size and forecast, by end user
7.2.7.Canada
7.2.7.1.Canada market size and forecast, by route of administration
7.2.7.2.Canada market size and forecast, by application
7.2.7.3.Canada market size and forecast, by end user
7.2.8.Mexico
7.2.8.1.Mexico market size and forecast, by route of administration
7.2.8.2.Mexico market size and forecast, by application
7.2.8.3.Mexico market size and forecast, by end user
7.3.Europe
7.3.1.Key trends and opportunities
7.3.2.Europe market size and forecast, by country
7.3.3.Europe market size and forecast, by route of administration
7.3.4.Europe market size and forecast, by application
7.3.5.Europe market size and forecast, by end user
7.3.6.Germany
7.3.6.1.Germany market size and forecast, by route of administration
7.3.6.2.Germany market size and forecast, by application
7.3.6.3.Germany market size and forecast, by end user
7.3.7.UK
7.3.7.1.UK market size and forecast, by route of administration
7.3.7.2.UK market size and forecast, by application
7.3.7.3.UK market size and forecast, by end user
7.3.8.Spain
7.3.8.1.Spain market size and forecast, by route of administration
7.3.8.2.Spain market size and forecast, by application
7.3.8.3.Spain market size and forecast, by end user
7.3.9.France
7.3.9.1.France market size and forecast, by route of administration
7.3.9.2.France market size and forecast, by application
7.3.9.3.France market size and forecast, by end user
7.3.10.Italy
7.3.10.1.Italy market size and forecast, by route of administration
7.3.10.2.Italy market size and forecast, by application
7.3.10.3.Italy market size and forecast, by end user
7.3.11.Rest of Europe
7.3.11.1.Rest of Europe market size and forecast, by route of administration
7.3.11.2.Rest of Europe market size and forecast, by application
7.3.11.3.Rest of Europe market size and forecast, by end user
7.4.Asia-Pacific
7.4.1.Key trends and opportunities
7.4.2.Asia-Pacific market size and forecast, by country
7.4.3.Asia-Pacific market size and forecast, by route of administration
7.4.4.Asia-Pacific market size and forecast, by application
7.4.5.Asia-Pacific market size and forecast, by end user
7.4.6.Japan
7.4.6.1.Japan market size and forecast, by route of administration
7.4.6.2.Japan market size and forecast, by application
7.4.6.3.Japan market size and forecast, by end user
7.4.7.China
7.4.7.1.China market size and forecast, by route of administration
7.4.7.2.China market size and forecast, by application
7.4.7.3.China market size and forecast, by end user
7.4.8.India
7.4.8.1.India market size and forecast, by route of administration
7.4.8.2.India market size and forecast, by application
7.4.8.3.India market size and forecast, by end user
7.4.9.Australia
7.4.9.1.Australia market size and forecast, by route of administration
7.4.9.2.Australia market size and forecast, by application
7.4.9.3.Australia market size and forecast, by end user
7.4.10.Rest of Asia-Pacific
7.4.10.1.Rest of Asia-Pacific market size and forecast, by route of administration
7.4.10.2.Rest of Asia-Pacific market size and forecast, by application
7.4.10.3.Rest of Asia-Pacific market size and forecast, by end user
7.5.LAMEA
7.5.1.Key market trends and opportunities
7.5.2.LAMEA market size and forecast, by country
7.5.3.LAMEA market size and forecast, by route of administration
7.5.4.LAMEA market size and forecast, by application
7.5.5.LAMEA market size and forecast, by end user
7.5.6.Brazil
7.5.6.1.Brazil market size and forecast, by route of administration
7.5.6.2.Brazil market size and forecast, by application
7.5.6.3.Brazil market size and forecast, by end user
7.5.7.South Africa
7.5.7.1.South Africa market size and forecast, by route of administration
7.5.7.2.South Africa market size and forecast, by application
7.5.7.3.South Africa market size and forecast, by end user
7.5.8.Saudi Arabia
7.5.8.1.Saudi Arabia market size and forecast, by route of administration
7.5.8.2.Saudi Arabia market size and forecast, by application
7.5.8.3.Saudi Arabia market size and forecast, by end user
7.5.9.Rest of LAMEA
7.5.9.1.Rest of LAMEA market size and forecast, by route of administration
7.5.9.2.Rest of LAMEA market size and forecast, by application
7.5.9.3.Rest of LAMEA market size and forecast, by end user
CHAPTER 8:COMPANY PROFILES
8.1.Abbott Laboratories
8.1.1.Company overview
8.1.2.Company snapshot
8.1.3.Operating business segments
8.1.4.Product portfolio
8.1.5.Business performance
8.2.B. BRAUN MELSUNGEN AG
8.2.1.Company overview
8.2.2.Company snapshot
8.2.3.Operating business segments
8.2.4.Product Portfolio
8.2.5.B. BRAUN operates through the following product:
8.2.6.Business performance
8.3.BAXTER INTERNATIONAL INC.
8.3.1.Company overview
8.3.2.Company snapshot
8.3.3.Operating business segments
8.3.4.Product Portfolio
8.3.5.Business performance
8.3.6.Key strategic moves and development
8.4.Danone Nutricia
8.4.1.Company overview
8.4.2.Company snapshot
8.4.3.Operating business segments
8.4.4.Product portfolio
8.5.Fresenius SE & Co. KGaA
8.5.1.Company overview
8.5.2.Company snapshot
8.5.3.Operating business segments
8.5.4.Product portfolio
8.5.5.Business performance
8.6.Hero Nutritionals Inc.
8.6.1.Company overview
8.6.2.Company snapshot
8.6.3.Operating business segments
8.6.4.Product portfolio
8.7.Lonza Ltd.
8.7.1.Company overview
8.7.2.Company snapshot
8.7.3.Operating business segments
8.7.4.Product portfolio
8.7.5.Business performance
8.7.6.Key strategic moves and developments
8.8.NESTL S.A.
8.8.1.Company overview
8.8.2.Company snapshot
8.8.3.Operating business segments
8.8.4.Product portfolio
8.8.5.Business performance
8.9.PERRIGO COMPANY PLC
8.9.1.Company overview
8.9.2.Company snapshot
8.9.3.Operating business segments
8.9.4.Product portfolio
8.9.5.Business performance
8.10.Pfizer Inc.
8.10.1.Company overview
8.10.2.Company snapshot
8.10.3.Operating business segments
8.10.4.Product portfolio
8.10.5.Business performance
Call Us
( India toll free )
+91 835 605 0278
( US toll free )
+1 800 601 6071
Drop us an email at
sales@prudentmarkets.com
Get your pre and post sales queries resolved by our Subject matter experts.
We will assist you to customize the report to fit your research needs.
Our prime focus is to provide qualitative and accurate data.
Feel free to order a sample report before purchase.
Your personal and confidential information is safe and secured.
